Skip links

OncoOne proudly announces the completion of its first academic thesis.

On May 15, 2021, in Vienna, Austria, OncoOne proudly announces the completion of its first academic thesis. Our team member, Gregor Rossmüller, has successfully conducted and finalized his master’s thesis titled “Purification and characterization of anti-CD3/anti-oxMIF bispecific antibodies or antibody-like molecules for the treatment of solid tumors” at OncoOne in collaboration with University of Natural Resources and Applied Life Sciences (BOKU),Vienna. Gregor graduated as Master of Science (MSc).

Home